Important Message to Our Clients

As the COVID-19 coronavirus continues to spread around the globe and disrupt both life and financial markets, your healthcare bankers at Oppenheimer & Co. Inc. remain committed to providing you with timely insight and advisory solutions. We are here to assist you with advice that may include resiliency of your operations, capital and liquidity, business modeling, and opportunistic situations arising during this time. Given the need for a rapid response to the problem, the world is depending on our industries to work overtime and to spare no expense to improve testing and develop antiviral therapies and vaccines to combat the threat.

While Oppenheimer & Co. Inc. has instituted the necessary proactive and prudent actions to protect our employees, their families, and clients, our healthcare investment banking team is available to you and is conducting business as usual using virtual and digital methods. Our annual Healthcare Conference is now a virtual conference with Dr. Scott Gottlieb providing the keynote address to discuss his outlook on the coronavirus outbreak. Learn more about Dr. Gottlieb and watch our video on the important topics that will be covered on this conference call.

Our team has continued to deliver strong deal execution in this turbulent environment, including bookrun financings for Agile Therapeutics, Marinus Pharmaceuticals, Catabasis Pharmaceuticals, aTyr Pharma, Essa Pharma, VBI Vaccines, Sunesis Pharmaceuticals, and Miragen Therapeutics.

As part of our commitment to clients, we are available at any time. Please feel free to reach out to your investment banking representative.